Drug-related license administration to be streamlined

The Korea Food and Drug Administration has announced that a serious of measures have been adopted to streamline procedures for drug-related license administration and thus ensure transparency in screening drug-related applications:

- In case a manufacturing and/or import license is sought for a new chemical drug (e.g., amlodipine maleate) or other items identical with those in terms of acti...